Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Supplementing your income for bills is essential for financial stability. Explore various methods to increase your earnings.
14,005 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Nu Holdings has shown impressive growth, but the true challenge lies in weathering a credit cycle. This guide explain...
Investors are jittery as AI powerhouses push for faster adoption, while critics warn of overhype. This piece breaks d...
Universal Corp misses EPS and swings to a loss in the third quarter, triggering a double-digit stock drop. Analysts f...
Campbell’s posts worst quarters as revenue and margins deteriorate across key segments. The company trims full-year t...
Joe Kent, a former Army Special Forces officer and two-time congressional candidate, quit today from a top counterter...
As SoFi expands beyond student loan refi, the question for investors is clear: where will SoFi Technologies be in fiv...
SoFi faced a high-profile attack from a famed short-seller, sending shares lower. This deep dive explains what the re...
United Wholesale Mortgage reports a profitable first quarter as originations slow. CEO Mat Ishbia escalates pressure ...
As Xeris prepares to unpack its Q1 2026 results, investors want clarity on revenue, cash runway, and pipeline milesto...
Rising rates don’t have to stop your rental plans. This guide breaks down actionable strategies to land cash-flowing ...
Analysts and investors are watching KLXE's Q1 2026 earnings closely. This article breaks down the transcript, interpr...